C H Sogaard
Overview
Explore the profile of C H Sogaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sogaard C, Mosekilde L, Thomsen J, Richards A, McOsker J
Bone
. 1997 May;
20(5):439-49.
PMID: 9145241
The aim of this investigation was to compare the effects of sodium fluoride (NaF) and parathyroid hormone (PTH) on ash density and strength in an osteopenic rat model. The study...
2.
Li M, Mosekilde L, Sogaard C, Thomsen J, Wronski T
Bone
. 1995 Jun;
16(6):629-35.
PMID: 7669439
Previous studies have shown that parathyroid hormone (PTH) monotherapy and cotherapy with estrogen or risedronate augment vertebral bone mass and bone strength in young, ovariectomized (OVX) rats. The current study...
3.
Sogaard C, Richards A, Mosekilde L
Ugeskr Laeger
. 1995 Apr;
157(14):2004-8.
PMID: 7740640
In order to evaluate the effect of sodium fluoride (NaF) on bone biomechanical competence, iliac crest biopsies were taken before and after one year of treatment in 12 osteoporotic patients,...
4.
Mosekilde L, Danielsen C, Sogaard C, McOsker J, Wronski T
Bone
. 1995 Feb;
16(2):223-30.
PMID: 7756051
The aim of the study was to determine the effect of parathyroid hormone (PTH), the antiresorptive agents estrogen and bisphosphonate (risedronate), and also the combination of PTH with these antiresorptive...
5.
Sogaard C, Mosekilde L, Schwartz W, Leidig G, Minne H, Ziegler R
Bone
. 1995 Jan;
16(1):163-9.
PMID: 7742076
For more than 30 years, sodium fluoride has been a commonly used therapeutic agent for established osteoporosis because of its repeatedly documented anabolic effect on trabecular bone mass. Recent clinical...
6.
Sogaard C, Hermann A, Hasling C, Mosekilde L
Osteoporos Int
. 1994 Jul;
4(4):211-9.
PMID: 7949751
Bone densitometric measurements are widely used for monitoring therapeutic regimens for osteoporosis. However, it is a matter of debate which measurement site is most appropriate for prediction of individual fracture...
7.
Mosekilde L, Sogaard C, McOsker J, Wronski T
Bone
. 1994 Jul;
15(4):401-8.
PMID: 7917578
The aim of the study was to determine the effect of PTH, the antiresorptive agents estrogen and bisphosphonate (Risedronate), and also the combination of PTH with the antiresorptive drugs on...
8.
Sogaard C, Richards A, Mosekilde L
Bone
. 1994 Jul;
15(4):393-9.
PMID: 7917577
Sodium fluoride has for more than 2 decades been a commonly used therapeutic agent for established osteoporosis because of a repeatedly documented anabolic effect on trabecular bone mass. Recently, however,...
9.
Mosekilde L, Danielsen C, Sogaard C, Thorling E
Bone
. 1994 May;
15(3):293-301.
PMID: 8068450
The rat model has previously been used to test the effect of ovariectomy and of PTH administration on vertebral bone mass, size, and biomechanical competence. In this study, we used...
10.
Sogaard C, Danielsen C, Thorling E, Mosekilde L
J Bone Miner Res
. 1994 Mar;
9(3):409-16.
PMID: 8191936
The present study was designed to examine the effect of exercise on femoral neck bone structure and strength in female rats after 4 and 10 months of exercise. Female Fischer...